been infected early in pregnancy. 8 The risk of birth defects has been estimated to range from 6% to 42%, and there were probably 2000 cases of microcephaly in the South American outbreak.
The answer to our question posed in the title of this editorial is that ZIKV is almost everywhere in our region. The US Centers for Disease Control and Prevention advise that Zika is present in India and Bangladesh as well as throughout all of South East Asia in Indonesia, Papua New Guinea, Philippines, Vietnam, Laos, Cambodia, Thailand, Myanmar, Malaysia, and in the Pacific Islands. 9 But for some reason, higher than normal rates of microcephaly are not being reported. However, a recent outbreak of Guillain-Barré syndrome in adults in Bangladesh has been associated with ZIKV. 10 A puzzling question is to why if the virus is so widespread, does the incidence of microcephaly and other neuro-defects appear to have declined? Zika is an RNA virus, which are known to mutate frequently. Is it "changing its spots" regularly and becoming less teratogenic? ZIKV is structurally similar to the dengue virus. Immunity to dengue is complex and some vaccines that have been trialed have produced severe disease when subsequent infections have occurred. There may be some synergy in the body's reaction if infections with Zika and dengue occur simultaneously. There are reports that Guillain-Barré syndrome is more common in patients infected with both viruses. 11 The complex immunology will make the development of a vaccine more difficult.
Climate change is enabling the mosquito vectors to increase the range of their habitats, and we can expect more countries in our region to experience Zika epidemics. 12 The citizens of the world, and of course the Asia Pacific region, are protected from the threats of epidemics of infections by networks of government and academic institutions. Our governmental organizations are linked by regional and global networks (eg, World Health Organization, United Nations International Children's Emergency Fund) while university and other learned groups also form collaborative organizations, such as Asia Pacific Academic Consortium for Public Health (APACPH), for sharing of information about outbreaks, research, and education. We do not know if or when a further outbreak of neurological abnormalities caused by ZIKV will occur. Monitoring for adverse birth outcomes is important and requires constant surveillance and reporting to a central registry. It is made more difficult by the constant "background noise" of a low level of serious birth defects that constantly occur. 13 In the advent of a new outbreak, the traditional public approaches of case detection, vector monitoring, and control as well as personal protection will be needed. This is a continuing emphasis of the traditional public health programs of APACPH members, while our laboratory colleagues continue their search for a vaccine.
